[ad_1]
The Swiss pharmaceutical company Roche publishes the results of a study on a new influenza treatment that has proven effective in people with major complications.
According to this study, the new drug "Bauxafeer Marboxil" was its main target. Coping with the flu more than other drugs has not been able to prevent the virus from infiltrating the body. Influenza can cause serious complications in people over 65 years of age or with asthma, diabetes, chronic lung disease or cardiovascular disease.
These complications lead to hospitalization and sometimes death.
[ad_2]
Source link
